Analytical Data
-
Gene name
PMAP36
- Application
-
Alternative Names
Myeloid antibacterial peptide 36
-
Species
Pig
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P49931
-
Expression Region
130-166aa
-
Molecular Weight
20.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PMAP36 (Porcine Major Acute Phase Protein 36) is a protein associated with the acute phase response in pigs, playing a crucial role in the immune system's reaction to inflammation and infection. Research on PMAP36 is increasingly important due to its potential applications in veterinary medicine and animal husbandry. With growing concerns over animal health and welfare, understanding the molecular mechanisms underlying PMAP36's function can lead to improved strategies for disease management in swine populations. The protein's involvement in the acute inflammatory response suggests that it could serve as a biomarker for disease susceptibility or progression, providing insights into pig health status. Moreover, PMAP36 is believed to possess antimicrobial properties, making it a focal point for developing new therapeutic approaches against infections in livestock. Recombinant PMAP36 studies enable researchers to dissect its biological activity and interactions with various pathogens, ultimately contributing to the field of immunology and enhancing the efficacy of vaccines and treatments. As the global demand for pork continues to rise, leveraging the insights gained from PMAP36 research could significantly improve animal health, welfare, and productivity, addressing both economic and ethical concerns within the industry.
